$1.31
-0.01-1.13%
At Close: -
$1.34
0.032.29%
After Hours: 9:28 AM EDT
15 minutes delayed
Spero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Spero Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics | -$0.23 | -$0.38 | — | — | $2.72M | $3.27M | — | — | 08/08/2024 | Get Alert |
SPRO | Spero Therapeutics | -$0.25 | -$0.04 | -$0.24 | -500.00% | $2.07M | $21.53M | $9.27M | -56.96% | 05/15/2024 | Get Alert |
SPRO | Spero Therapeutics | $0.55 | -$0.10 | $0.96 | 1060.00% | $47.44M | $18.63M | $73.52M | 294.65% | 03/13/2024 | Get Alert |
SPRO | Spero Therapeutics | -$0.33 | -$0.03 | -$0.06 | -100.00% | $2.01M | $14.97M | $25.47M | 70.16% | 11/13/2023 | Get Alert |
SPRO | Spero Therapeutics | -$0.51 | -$0.34 | -$0.23 | 32.35% | $1.99M | $1.07M | $2.72M | 153.83% | 08/10/2023 | Get Alert |
SPRO | Spero Therapeutics | -$1.01 | -$0.33 | -$0.25 | 24.24% | $2.07M | $1.00M | $2.07M | 106.90% | 05/11/2023 | Get Alert |
SPRO | Spero Therapeutics | -$0.90 | $0.04 | $0.55 | 1275.00% | $2.74M | $22.87M | $47.44M | 107.44% | 03/30/2023 | Get Alert |
SPRO | Spero Therapeutics | -$0.70 | -$0.30 | -$0.33 | -10.00% | $3.06M | $5.42M | $2.01M | -62.99% | 11/14/2022 | Get Alert |
SPRO | Spero Therapeutics | -$0.63 | -$0.54 | -$0.51 | 5.56% | $5.15M | $1.15M | $1.99M | 73.30% | 08/10/2022 | Get Alert |
SPRO | Spero Therapeutics | -$0.66 | -$0.87 | -$1.01 | -16.09% | $7.30M | $2.57M | $2.07M | -19.49% | 05/16/2022 | Get Alert |
SPRO | Spero Therapeutics | -$0.68 | -$0.75 | -$0.90 | -20.00% | $1.91M | $4.95M | $2.74M | -44.57% | 03/31/2022 | Get Alert |
SPRO | Spero Therapeutics | -$0.86 | -$0.66 | -$0.70 | -6.06% | $4.00M | $4.47M | $3.06M | -31.45% | 11/10/2021 | Get Alert |
SPRO | Spero Therapeutics | -$0.85 | -$0.77 | -$0.63 | 18.18% | $1.73M | $4.03M | $5.15M | 27.74% | 08/05/2021 | Get Alert |
SPRO | Spero Therapeutics | -$1.22 | -$0.64 | -$0.66 | -3.12% | $1.70M | $3.16M | $7.30M | 131.01% | 05/06/2021 | Get Alert |
SPRO | Spero Therapeutics | -$1.32 | -$0.74 | -$0.68 | 8.11% | $3.63M | $3.67M | $1.91M | -48.04% | 03/11/2021 | Get Alert |
SPRO | Spero Therapeutics | -$0.95 | -$0.87 | -$0.86 | 1.15% | $4.64M | $3.20M | $4.00M | 24.84% | 11/05/2020 | Get Alert |
SPRO | Spero Therapeutics | -$0.74 | -$1.12 | -$0.85 | 24.11% | $2.16M | $3.40M | $1.73M | -49.21% | 08/06/2020 | Get Alert |
SPRO | Spero Therapeutics | -$0.29 | -$1.25 | -$1.22 | 2.40% | $7.72M | $3.44M | $1.70M | -50.55% | 05/08/2020 | Get Alert |
SPRO | Spero Therapeutics | -$0.60 | — | -$1.32 | — | $1.69M | — | $3.63M | — | 03/16/2020 | Get Alert |
SPRO | Spero Therapeutics | -$0.60 | -$0.85 | -$0.95 | -11.76% | $658.00K | $2.45M | $4.64M | 89.51% | 11/04/2019 | Get Alert |
SPRO | Spero Therapeutics | -$0.69 | -$0.65 | -$0.74 | -13.85% | $463.00K | $5.05M | $2.16M | -57.31% | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.24 | $-0.04 | -500.0 % |
Dec 2023 | 2024-03-13 | $0.96 | $-0.10 | 1060.0 % |
Sep 2023 | 2023-11-13 | $-0.06 | $-0.03 | -100.0 % |
Jun 2023 | 2023-08-10 | $-0.23 | $-0.34 | 32.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $9.27M | $21.53M | -57.0 % |
Dec 2023 | 2024-03-13 | $73.52M | $18.63M | 294.6 % |
Sep 2023 | 2023-11-13 | $25.47M | $14.97M | 70.2 % |
Jun 2023 | 2023-08-10 | $2.72M | $1.07M | 153.8 % |
Spero Therapeutics (SPRO) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
The Actual EPS was $-0.24, which missed the estimate of $-0.04.
The Actual Revenue was $9.3M, which missed the estimate of $21.5M.
Browse earnings estimates, EPS, and revenue on all stocks.